Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (10)

2021

  1. Influence of elevated sleep-time blood pressure on vascular risk and hypertension-mediated organ damage

    Chronobiology International, Vol. 38, Núm. 3, pp. 367-377

2019

  1. Hypertension exhibits 5-HT 4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature

    Hypertension Research, Vol. 42, Núm. 5, pp. 618-627

2017

  1. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT1D sympatholytic receptors

    Clinical and Experimental Pharmacology and Physiology, Vol. 44, Núm. 12, pp. 1224-1231

2013

  1. Alteration in Endoglin-Related Angiogenesis in Refractory Cytopenia with Multilineage Dysplasia

    PLoS ONE, Vol. 8, Núm. 1

2008

  1. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

  2. The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 11, pp. 3403-3411

2007

  1. Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients

    Cancer Letters, Vol. 255, Núm. 1, pp. 71-76

2005

  1. Gentamicin induces Jun-AP1 expression and JNK activation in renal glomeruli and cultured mesangial cells

    Life Sciences, Vol. 77, Núm. 18, pp. 2285-2298

2004

  1. Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure

    Nephrology Dialysis Transplantation, Vol. 19, Núm. 1, pp. 83-94

2001

  1. Endoglin expression in human and rat mesangial cells and its upregulation by TGF-β1

    Biochemical and Biophysical Research Communications, Vol. 282, Núm. 1, pp. 142-147